NIDDK Home Welcome Health Information Research Funding Opportunities Research Areas NIDDK Will Fund You are here: Current Funding Opportunities NIDDK Funding Strategies Conferences and Workshops Division Organization Research Training and Career Development Research Centers Grants and Contracts Process Grantee Responsibilities Grant Review Information Research Tools and Resources Clinical Trials NIDDK Laboratories (Intramural) Reports, Testimony & Planning
Bypass navigation and tool bar
NIDDK logo
navigation bar
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Site Map FAQs Contact NIDDK
NIDDK Home : Research Funding : NIDDK SBIR/STTR program

NIDDK SBIR / STTR Program

  • Current Initiatives
  • Archived Initiatives
  • SBIR/STTR Program
  • Small Business Innovation Research (SBIR)
  • Small Business Technology Transfer (STTR)
  • SBIR/STTR Research Topics
  • Additional Information

    Small Business Innovation Research (SBIR)

    The NIH SBIR program is intended to support innovative research, conducted by small business concerns, which has the potential for commercialization. The program is designed in a two-step fashion where applicants submit a feasibility, or Phase I, application that is peer-reviewed. Typically these applications seek up to $100,000 for 6 months of research support. Successful recipients of Phase I funds may then submit Phase II applications, for both a longer duration (usually 2 years) and a larger amount (usually up to $750,000)of support. The funds for this program are 'set-aside' and therefore do not compete with the regular research, training, or other special programs supported by the Institutes.

    In fiscal year (FY) 2002 (October 1, 2002-September 30, 2002), the NIH issued SBIR and STTR grant and contract awards totaling over $490 million.

    NIDDK awarded over $32 million in SBIR grants and $1.7 million in STTR grants in FY 2002.

    [Top]

    Small Business Technology Transfer (STTR)

    The NIH STTR program is similar to the SBIR, but requires that the small business concern partner with a research institution to perform the project that will lead to a commercial product.

    The major differences between the Small Business Innovation Research (SBIR) and the Small Business Technology Transfer (STTR) program are itemized below. This list is meant to provide you with enough information to help you decide to which program you should apply. Consultation with program staff is always encouraged if questions arise.

    • The set-aside for the SBIR program is 2.5% of the extramural budget; the set-aside for the STTR program is 0.15% of the extramural budget.

    • In Phase I SBIR grants, a minimum of 2/3 of the work MUST be performed by the small business concern; in Phase I STTR grants, a minimum of 40% of the work MUST be performed by the small business concern AND a minimum of 30% MUST be performed by the research institution.

    • In Phase II SBIR grants, a minimum of 50% of the work MUST be performed by the small business concern; in phase II STTR grants, the same requirements as Phase I grants must be followed, i.e. a minimum of 40% of the work MUST be performed by the small business, a minimum of 30% by the research institution.

    • For SBIR grants, the Principal Investigator must have his/her primary employment with the small business concern; for STTR grants, someone at either the small business concern or the research institution may be the P.I.

    • SBIR/STTR Application Instructions (PDF) | Forms

    • Federal Financial and Business Management Systems Requirement - Sample Policies and Procedures
    [Top]

    SBIR/STTR Research Topics

    Refer to the NIDDK Current Initiatives for SBIR and STTR initiative listings.

    SBIR/STTR research topics are listed in the NIDDK section of the NIH Omnibus Solicitation (PDF).

    [Top]

    Additional Information

    Applications may be submitted for any of the yearly receipt dates of April 1, August 1, and December 1.

    For more information, contact your NIDDK Program Director:

    DIABETES, ENDOCRINOLOGY AND METABOLIC DISEASES
    Islet Transplantation
    Dr. Thomas Eggerman
    (301) 594-8813 Fax: (301) 480-3510
    Email: te39q@nih.gov
    Diabetes Therapy and Prevention
    Dr. Sanford Garfield
    (301) 594-8803 Fax: (301) 480-6271
    Email: sg50o@nih.gov
    Gene Therapy, Metabolic Diseases, and Cystic Fibrosis
    Dr. Catherine McKeon
    (301) 594-8810 Fax: (301) 480-3503
    Email: cm67w@nih.gov
    Proteomics, Glucose Sensors, Metabolic Profiling, and Hormone Action
    Dr. Salvatore Sechi
    (301) 594-8814 Fax: (301) 480-8814
    Email: ss24q@nih.gov
    DIGESTIVE DISEASES AND NUTRITION
    Digestive and Liver Diseases (Clinical)
    Dr. Frank Hamilton
    (301) 594-8877 Fax: (301) 480-8300
    Email: fh14e@nih.gov
    Digestive and Liver Diseases (Basic)
    Dr. Judith Podskalny
    (301) 594-3197 Fax: (301) 480-8300
    Email: jp53s@nih.gov
    Nutrition
    Dr. M. Ken May
    (301) 594-8884 Fax: (301) 480-8300
    Email: mm102i@nih.gov
    Obesity and Eating Disorders
    Carolyn Miles
    (301) 451-3759 Fax: (301) 480-8300
    Email: milesc@extra.niddk.nih.gov
    KIDNEY, UROLOGIC AND HEMATOLOGIC DISEASES
    Kidney
    Dr. Robert A. Star
    (301) 594-7717 Fax: (301) 480-3510
    Email: rs301p@nih.gov
    Urology
    Dr. Leroy M. Nyberg
    (301) 594-7717 Fax: (301) 480-3510
    Email: ln10f@nih.gov
    Hematology
    Dr. David G. Badman
    (301) 594-7717 Fax: (301) 480-3510
    Email: db70f@nih.gov
     


    For administrative and business management questions, contact:

    Mrs. Helen Ling
    Grants Management Specialist
    National Institute of Diabetes and Digestive and Kidney Diseases
    Democracy 2, Room 732
    phone: (301) 594-8857;
    Fax: (301) 480-3504;
    email: lingh@extra.niddk.nih.gov



     

    [Top]


  • Director: Dr. Allen Spiegel || Contact NIDDK
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the National Institutes of Health, Bethesda, MD, USA. General inquiries may be addressed to Office of Communications and Public Liaison, NIDDK, NIH, Building 31, room 9A04 Center Drive, MSC 2560, Bethesda, MD 20892-2560, USA. || Privacy || Disclaimer || Copyright || Credits || Accessibility

    U. S. National Institutes of Health U.S. Department of Health & Human Services FirstGov